337 related articles for article (PubMed ID: 37243293)
1. Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant
Racenis K; Lacis J; Rezevska D; Mukane L; Vilde A; Putnins I; Djebara S; Merabishvili M; Pirnay JP; Kalnina M; Petersons A; Stradins P; Maurins S; Kroica J
Viruses; 2023 May; 15(5):. PubMed ID: 37243293
[TBL] [Abstract][Full Text] [Related]
2.
Aslam S; Roach D; Nikolich MP; Biswas B; Schooley RT; Lilly-Bishop KA; Rice GK; Cer RZ; Hamilton T; Henry M; Luong T; Salabarria A-C; Sisk-Hackworth L; Filippov AA; Lebreton F; Hall L; Nir-Paz R; Onallah H; Livni G; Shostak E; Wieder-Finesod A; Yahav D; Yerushalmy O; Alkalay-Oren S; Braunstein R; Khalifa L; Rimon A; Gelman D; Hazan R
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0172823. PubMed ID: 38470133
[TBL] [Abstract][Full Text] [Related]
3. Activity of Bacteriophages in Removing Biofilms of
Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
[No Abstract] [Full Text] [Related]
4. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L
Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933
[TBL] [Abstract][Full Text] [Related]
5. Phage-antibiotic combinations against multidrug-resistant
Holger DJ; El Ghali A; Bhutani N; Lev KL; Stamper K; Kebriaei R; Kunz Coyne AJ; Morrisette T; Shah R; Alexander J; Lehman SM; Rojas LJ; Marshall SH; Bonomo RA; Rybak MJ
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0057823. PubMed ID: 37855639
[TBL] [Abstract][Full Text] [Related]
6. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa.
Tkhilaishvili T; Winkler T; Müller M; Perka C; Trampuz A
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31527029
[TBL] [Abstract][Full Text] [Related]
9. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa.
Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M
Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial efficacy of lytic phages against multidrug-resistant Pseudomonas aeruginosa infections in bacteraemia mice models.
Arumugam SN; Manohar P; Sukumaran S; Sadagopan S; Loh B; Leptihn S; Nachimuthu R
BMC Microbiol; 2022 Aug; 22(1):187. PubMed ID: 35909125
[TBL] [Abstract][Full Text] [Related]
11. Improving the Inhibitory Effect of Phages against
Aghaee BL; Khan Mirzaei M; Alikhani MY; Mojtahedi A; Maurice CF
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670028
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
Shariati A; Noei M; Chegini Z
J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
[TBL] [Abstract][Full Text] [Related]
13. Alginate microbeads and hydrogels delivering meropenem and bacteriophages to treat Pseudomonas aeruginosa fracture-related infections.
Chen B; Benavente LP; Chittò M; Wychowaniec JK; Post V; D'Este M; Constant C; Zeiter S; Feng W; Moreno MG; Trampuz A; Wagemans J; Onsea J; Richards RG; Lavigne R; Moriarty TF; Metsemakers WJ
J Control Release; 2023 Dec; 364():159-173. PubMed ID: 37866403
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing.
Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ
J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690
[TBL] [Abstract][Full Text] [Related]
17. Use of Phage Cocktail BFC 1.10 in Combination With Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant
Racenis K; Rezevska D; Madelane M; Lavrinovics E; Djebara S; Petersons A; Kroica J
Front Med (Lausanne); 2022; 9():851310. PubMed ID: 35547216
[TBL] [Abstract][Full Text] [Related]
18. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
[TBL] [Abstract][Full Text] [Related]
19. Resistance Evolution against Phage Combinations Depends on the Timing and Order of Exposure.
Wright RCT; Friman VP; Smith MCM; Brockhurst MA
mBio; 2019 Sep; 10(5):. PubMed ID: 31551330
[TBL] [Abstract][Full Text] [Related]
20. Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant.
Peghin M; Maiani M; Castaldo N; Givone F; Righi E; Lechiancole A; Sartor A; Pea F; Livi U; Bassetti M
Infection; 2018 Apr; 46(2):263-265. PubMed ID: 29086895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
